Study reveals candidate targets for anti-retroviral therapeutics
Scientists at Cold Spring Harbor Laboratory identified 130 genes that affect the replication of retrovirus-like elements in yeast. These genes have clear relatives or homologs in the human genome, providing a rich source for candidate host genes to develop new anti-retroviral therapeutics.